E-LIB Suche - Ergebnisse für: Palomba, K.

1

O08: Influence de la concentration des compléments nutritio..:

Galmiche, M. ; Alessandrini, E. ; Eyrault, E....
Nutrition Clinique et Métabolisme. 28 (2014) - p. S32-S33 , 2014

Link: https://doi.org/10.1016/..

2

P262: Évaluation du caractère prédictif de l'échelle visuel..:

Galmiche, M. ; Besnard, I. ; Palomba, K....
Nutrition Clinique et Métabolisme. 28 (2014) - p. S206 , 2014

Link: https://doi.org/10.1016/..

3

255 Are Certain PECARN Criteria Too Subjective to Be Accura..:

Bastani, A. ; Donaldson, D. ; Shah, P....
Annals of Emergency Medicine. 60 (2012) 4 - p. S92 , 2012

Link: https://doi.org/10.1016/..

4

PP062-MON HUMAN CHEMOKINE PROFILE IN CANCER ANOREXIA AND CA..:

Zeanandin, G. ; Rovere, C. ; Cazareth, J....
Clinical Nutrition Supplements. 7 (2012) 1 - p. 162 , 2012

Link: https://doi.org/10.1016/..

5

5 Protecting Those Who Cannot Protect Themselves:

Peraino, A. ; Donaldson, D. ; Shah, P....
Annals of Emergency Medicine. 60 (2012) 4 - p. S2-S3 , 2012

Link: https://doi.org/10.1016/..

6

P175 Évaluation d'un nouveau complément nutritionnel oral g..:

Besnard, I. ; Eyraud, E. ; Palomba, K....
Nutrition Clinique et Métabolisme. 25 (2011) - p. S137-S138 , 2011

Link: https://doi.org/10.1016/..

7

O43 Étude chez l'homme du profil des chimiokines dans l'ano..:

Rovère, C. ; Zeanandin, G. ; Cazareth, J....
Nutrition Clinique et Métabolisme. 25 (2011) - p. S41-S42 , 2011

Link: https://doi.org/10.1016/..

8

Scientific Objectives of Einstein Telescope:

Sathyaprakash, B ; Abernathy, M ; Acernese, F...
http://arxiv.org/abs/1206.0331. , 2012

Link: http://arxiv.org/abs/120..

9

LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN R/R MCL: PRIMARY ANA..:

Wang, M. ; Siddiqi, T. ; Gordon, L. I....
Hematological Oncology. 41 (2023) S2 - p. 875-877 , 2023

Link: https://doi.org/10.1002/..

10

PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblas..:

Moskowitz, A. ; Savage, K. ; Feldman, T....
Hematological Oncology. 41 (2023) S2 - p. 351-353 , 2023

Link: https://doi.org/10.1002/..

11

CNS radiotherapy as bridging prior to CAR T‐cell therapy fo..:

Cederquist, G. ; Hubbeling, H. ; Tringale, K....
Hematological Oncology. 41 (2023) S2 - p. 530-532 , 2023

Link: https://doi.org/10.1002/..

12

A Phase I Study of CD19‐targeted 19(T2)28z1xx CAR T Cells i..:

Palomba, M. L. ; Riviere, I. ; Sikder, D. S....
Hematological Oncology. 41 (2023) S2 - p. 527-528 , 2023

Link: https://doi.org/10.1002/..

13

TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALE..:

Morschhauser, F. ; Dahiya, S. ; Palomba, M. L....
Hematological Oncology. 41 (2023) S2 - p. 877-880 , 2023

Link: https://doi.org/10.1002/..

14

PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DA..:

Torka, P. ; Feldman, T. ; Savage, K....
Hematological Oncology. 41 (2023) S2 - p. 161-162 , 2023

Link: https://doi.org/10.1002/..

15

Changes to physical activity behavior during the COVID-19 p..:

Stratton, Catherine ; Fourtassi, Maryam ; Ramia, Ioana...
BMC Women's Health. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..